biologics

LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.

Scientists engineer the photosynthetic bacteria spirulina to produce biologics at a large enough scale to treat some of the world’s deadliest and most prevalent diseases.

Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?